GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Piotroski F-Score

Labiana Health (XMAD:LAB) Piotroski F-Score : 0 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Labiana Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Labiana Health's Piotroski F-Score or its related term are showing as below:


Labiana Health Piotroski F-Score Historical Data

The historical data trend for Labiana Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Piotroski F-Score Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Piotroski F-Score
N/A N/A 4.00

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Piotroski F-Score N/A N/A - 4.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Net Income was €-8.94 Mil.
Cash Flow from Operations was €4.68 Mil.
Revenue was €57.85 Mil.
Gross Profit was €32.63 Mil.
Average Total Assets from the begining of this year (Dec21)
to the end of this year (Dec22) was (68.367 + 60.779) / 2 = €64.573 Mil.
Total Assets at the begining of this year (Dec21) was €68.37 Mil.
Long-Term Debt & Capital Lease Obligation was €18.19 Mil.
Total Current Assets was €28.76 Mil.
Total Current Liabilities was €35.07 Mil.
Net Income was €-1.78 Mil.

Revenue was €56.96 Mil.
Gross Profit was €35.00 Mil.
Average Total Assets from the begining of last year (Dec20)
to the end of last year (Dec21) was (65.977 + 68.367) / 2 = €67.172 Mil.
Total Assets at the begining of last year (Dec20) was €65.98 Mil.
Long-Term Debt & Capital Lease Obligation was €25.32 Mil.
Total Current Assets was €29.41 Mil.
Total Current Liabilities was €30.45 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Labiana Health's current Net Income (TTM) was -8.94. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Labiana Health's current Cash Flow from Operations (TTM) was 4.68. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec21)
=-8.943/68.367
=-0.13080872

ROA (Last Year)=Net Income/Total Assets (Dec20)
=-1.775/65.977
=-0.02690331

Labiana Health's return on assets of this year was -0.13080872. Labiana Health's return on assets of last year was -0.02690331. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Labiana Health's current Net Income (TTM) was -8.94. Labiana Health's current Cash Flow from Operations (TTM) was 4.68. ==> 4.68 > -8.94 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=18.189/64.573
=0.2816812

Gearing (Last Year: Dec21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec20 to Dec21
=25.321/67.172
=0.37695766

Labiana Health's gearing of this year was 0.2816812. Labiana Health's gearing of last year was 0.37695766. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec22)=Total Current Assets/Total Current Liabilities
=28.757/35.065
=0.82010552

Current Ratio (Last Year: Dec21)=Total Current Assets/Total Current Liabilities
=29.411/30.452
=0.96581505

Labiana Health's current ratio of this year was 0.82010552. Labiana Health's current ratio of last year was 0.96581505. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Labiana Health's number of shares in issue this year was 7.221. Labiana Health's number of shares in issue last year was 7.221. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=32.633/57.848
=0.5641163

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=34.997/56.956
=0.61445677

Labiana Health's gross margin of this year was 0.5641163. Labiana Health's gross margin of last year was 0.61445677. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec21)
=57.848/68.367
=0.84613922

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec20)
=56.956/65.977
=0.86327053

Labiana Health's asset turnover of this year was 0.84613922. Labiana Health's asset turnover of last year was 0.86327053. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Labiana Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Labiana Health  (XMAD:LAB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Labiana Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Labiana Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.